X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12123) 12123
Newsletter (317) 317
Magazine Article (126) 126
Newspaper Article (62) 62
Book Chapter (55) 55
Transcript (8) 8
Book / eBook (7) 7
Dissertation (4) 4
Conference Proceeding (3) 3
Reference (3) 3
Book Review (1) 1
Government Document (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9518) 9518
antifungal agents - therapeutic use (5757) 5757
male (4878) 4878
female (4593) 4593
antifungal agents - adverse effects (3478) 3478
adult (3368) 3368
middle aged (3279) 3279
antifungal agents - administration & dosage (2826) 2826
antifungal agents (2786) 2786
aged (2050) 2050
pharmacology & pharmacy (2016) 2016
treatment outcome (1846) 1846
infectious diseases (1815) 1815
microbiology (1596) 1596
antifungal agents - pharmacology (1492) 1492
mycoses (1464) 1464
fluconazole (1447) 1447
voriconazole (1438) 1438
animals (1368) 1368
adolescent (1343) 1343
mycoses - drug therapy (1330) 1330
health aspects (1255) 1255
amphotericin b - therapeutic use (1150) 1150
itraconazole (1101) 1101
dermatology (1100) 1100
risk factors (1071) 1071
transplantation (1062) 1062
infections (1032) 1032
immunology (1013) 1013
child (1012) 1012
candidiasis - drug therapy (983) 983
therapy (952) 952
care and treatment (950) 950
aspergillosis (918) 918
fungi (917) 917
amphotericin-b (916) 916
amphotericin b (885) 885
retrospective studies (880) 880
immunocompromised host (870) 870
antifungal agents - pharmacokinetics (865) 865
research (840) 840
drug therapy (828) 828
pharmacokinetics (806) 806
analysis (803) 803
fluconazole - therapeutic use (796) 796
administration, oral (783) 783
mycology (783) 783
aspergillosis - drug therapy (780) 780
fungal infections (780) 780
fungal-infections (777) 777
triazoles - therapeutic use (771) 771
young adult (760) 760
antifungal activity (758) 758
drug interactions (749) 749
antifungal (740) 740
infection (724) 724
microbial sensitivity tests (717) 717
epidemiology (704) 704
candidiasis (703) 703
amphotericin b - administration & dosage (672) 672
amphotericin b - adverse effects (666) 666
diagnosis (656) 656
drug therapy, combination (646) 646
mortality (627) 627
safety (620) 620
mycoses - prevention & control (599) 599
efficacy (593) 593
medicine & public health (587) 587
itraconazole - therapeutic use (586) 586
surgery (581) 581
child, preschool (576) 576
oncology (569) 569
fungicides (567) 567
hematology (558) 558
liposomal amphotericin-b (558) 558
aged, 80 and over (557) 557
cancer (556) 556
triazoles - adverse effects (556) 556
in-vitro (551) 551
pediatrics (544) 544
medicine, general & internal (542) 542
double-blind (527) 527
invasive fungal-infections (526) 526
terbinafine (524) 524
prophylaxis (514) 514
administration, topical (491) 491
infant (479) 479
onychomycosis - drug therapy (476) 476
management (475) 475
caspofungin (474) 474
prospective studies (473) 473
candida (472) 472
antifungals (468) 468
dosage and administration (467) 467
internal medicine (465) 465
triazoles - administration & dosage (460) 460
risk-factors (459) 459
dose-response relationship, drug (454) 454
ketoconazole (443) 443
pyrimidines - therapeutic use (428) 428
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11973) 11973
German (353) 353
Spanish (198) 198
French (165) 165
Japanese (131) 131
Portuguese (44) 44
Dutch (40) 40
Russian (38) 38
Chinese (36) 36
Italian (30) 30
Danish (23) 23
Polish (12) 12
Czech (9) 9
Hungarian (9) 9
Swedish (9) 9
Finnish (7) 7
Turkish (7) 7
Hebrew (6) 6
Norwegian (6) 6
Bulgarian (4) 4
Korean (4) 4
Serbian (4) 4
Lithuanian (2) 2
Persian (2) 2
Icelandic (1) 1
Romanian (1) 1
Slovak (1) 1
Slovenian (1) 1
Thai (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Current medical research and opinion, ISSN 1473-4877, 2012, Volume 29, Issue 1, pp. 1 - 12
...-related protease inhibitors. Rifabutin reduces serum concentrations of antiretroviral agents, but less so than rifampin... 
Rifabutin | Rifampin | Rifapentine | Drug interactions | MEDICINE, RESEARCH & EXPERIMENTAL | ENZYME-INDUCTION | PLATELET-AGGREGATION | ATORVASTATIN | SINGLE-BLIND | MEDICINE, GENERAL & INTERNAL | CLOPIDOGREL | PHARMACOKINETICS | METABOLISM | PLASMA-CONCENTRATIONS | HEALTHY-VOLUNTEERS | TRANSPORTER INHIBITION | Rifampin - analogs & derivatives | Simvastatin - therapeutic use | Antifungal Agents - adverse effects | Digoxin - adverse effects | Simvastatin - adverse effects | Antibiotics, Antitubercular - adverse effects | Humans | ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism | Antifungal Agents - therapeutic use | Rifampin - adverse effects | Verapamil - therapeutic use | Drug Interactions | Verapamil - adverse effects | Rifampin - therapeutic use | Contraceptives, Oral - adverse effects | Contraceptives, Oral - therapeutic use | Digoxin - therapeutic use | HIV Protease Inhibitors - adverse effects | Rifabutin - adverse effects | Anti-Arrhythmia Agents - therapeutic use | HIV Protease Inhibitors - therapeutic use | Anticholesteremic Agents - adverse effects | Itraconazole - therapeutic use | Anticholesteremic Agents - therapeutic use | Anti-Arrhythmia Agents - adverse effects | Itraconazole - adverse effects | Antibiotics, Antitubercular - therapeutic use | Cytochrome P-450 Enzyme System - biosynthesis | Rifabutin - therapeutic use | ATP Binding Cassette Transporter, Sub-Family B | Index Medicus
Journal Article
Archives of Dermatological Research, ISSN 0340-3696, 1/2009, Volume 301, Issue 1, pp. 99 - 105
Drug-induced lupus erythematosus (DILE) is defined as a lupus-like syndrome temporally related to continuous drug exposure which resolves after discontinuation... 
Drug-induced lupus erythematosus | Antinuclear antibodies (ANA) | Medicine & Public Health | Dermatology | Anti-TNFα-induced lupus | Anti-histone antibodies | Subacute cutaneous drug-induced lupus (SCLE) | Drug reactions | RHEUMATOID-ARTHRITIS | AUTOANTIBODIES | ANTINUCLEAR | NECROSIS-FACTOR-ALPHA | INDUCTION | DERMATOLOGY | Anti-TNF alpha-induced lupus | THERAPY | INFLIXIMAB | ASSOCIATION | EPIDEMIOLOGY | PSORIASIS | Antifungal Agents - adverse effects | Antitubercular Agents - adverse effects | Naphthalenes - adverse effects | Antibodies - metabolism | Calcium Channel Blockers - adverse effects | Serositis | Exanthema | Humans | Isoniazid - adverse effects | Interferons - adverse effects | Antihypertensive Agents - administration & dosage | Sodium Chloride Symporter Inhibitors - adverse effects | Arthritis | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Lupus Erythematosus, Systemic - immunology | Sodium Chloride Symporter Inhibitors - administration & dosage | Tumor Necrosis Factor-alpha - immunology | Antibodies - immunology | Lupus Erythematosus, Cutaneous - chemically induced | Procainamide - administration & dosage | Lupus Erythematosus, Cutaneous - immunology | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Anti-Arrhythmia Agents - administration & dosage | Procainamide - adverse effects | Antihypertensive Agents - adverse effects | Hydralazine - adverse effects | Isoniazid - administration & dosage | Lupus Erythematosus, Systemic - diagnosis | Interferons - administration & dosage | Hydralazine - administration & dosage | Animals | Anti-Arrhythmia Agents - adverse effects | Naphthalenes - administration & dosage | Calcium Channel Blockers - administration & dosage | Antitubercular Agents - administration & dosage | Lupus Erythematosus, Systemic - chemically induced | Antifungal Agents - administration & dosage | Lupus Erythematosus, Cutaneous - diagnosis | Lupus | Antigen-antibody reactions | Enzymes | Antigens | Biological products | Antibodies | Viral antibodies | Enzyme inhibitors | Systemic lupus erythematosus | Fluocinolone acetonide | Calcium channel blockers | Diuretics | Kidney diseases | Hydralazine | Index Medicus
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2017, Volume 152, Issue 5, pp. 1078 - 1089
... (OR, 2.0; 95% CI, 1.6-2.5; P = 9.7 x 10.sup.-9). The association with A*33:01 was mediated by large effects for terbinafine-, fenofibrate-, and ticlopidine-related DILI... 
Gastroenterology and Hepatology | Side Effect | Medication | Liver Damage | Anti-Fungal Agent | POPULATION | SUSCEPTIBILITY | RISK | TERBINAFINE | TICLOPIDINE | HEPATITIS | CLASS-I | HEPATOTOXICITY | GASTROENTEROLOGY & HEPATOLOGY | T-CELLS | ANTIGEN | Antifungal Agents - adverse effects | Naphthalenes - adverse effects | Humans | Middle Aged | Male | Sertraline - adverse effects | Fenofibrate - adverse effects | Chromosomes, Human, Pair 2 - genetics | Ticlopidine - adverse effects | Female | Odds Ratio | Chemical and Drug Induced Liver Injury - etiology | Platelet Aggregation Inhibitors - adverse effects | Hypolipidemic Agents - adverse effects | European Continental Ancestry Group - genetics | Genetic Predisposition to Disease | Genome-Wide Association Study | Genes, MHC Class I - genetics | Chemical and Drug Induced Liver Injury - genetics | Terbinafine | Phenotype | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Alleles | HLA-A Antigens - genetics | Polymorphism, Single Nucleotide | Antidepressive Agents - adverse effects | Drugs | Medical research | Liver diseases | Liver | Genes | Genomics | Risk factors | Genetic polymorphisms | Analysis | Gastrointestinal diseases | Medicine, Experimental | Genetic research | Trade and professional associations | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Hépatology and Gastroenterology | side effect | medication | anti-fungal agent | liver damage
Journal Article
Antimicrobial agents and chemotherapy, ISSN 1098-6596, 2012, Volume 56, Issue 9, pp. 4793 - 4799
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 03/2009, Volume 53, Issue 3, pp. 958 - 966
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
CELL TRANSPLANT RECIPIENTS | STEADY-STATE PHARMACOKINETICS | BEVERAGE COCA-COLA | SALVAGE THERAPY | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | FOOD INTERACTION | INVASIVE FUNGAL-INFECTION | ITRACONAZOLE | TRIAZOLE ANTIFUNGAL | VERSUS-HOST-DISEASE | FLUCONAZOLE | Triazoles - administration & dosage | Triazoles - adverse effects | Antifungal Agents - adverse effects | Triazoles - blood | Area Under Curve | Humans | Middle Aged | Omeprazole - blood | Intestinal Absorption - drug effects | Male | Anti-Ulcer Agents - blood | Gastric Mucosa - metabolism | Anti-Ulcer Agents - pharmacokinetics | Dose-Response Relationship, Drug | Young Adult | Antifungal Agents - pharmacokinetics | Hydrogen-Ion Concentration - drug effects | Gastric Mucosa - drug effects | Adult | Female | Triazoles - pharmacokinetics | Suspensions | Eating | European Continental Ancestry Group - genetics | Fasting | Drug Administration Schedule | Administration, Oral | Food-Drug Interactions | Omeprazole - administration & dosage | Anti-Ulcer Agents - adverse effects | African Americans - genetics | European Continental Ancestry Group - statistics & numerical data | Omeprazole - adverse effects | Omeprazole - pharmacokinetics | Carbonated Beverages | Anti-Ulcer Agents - administration & dosage | Cross-Over Studies | African Americans - statistics & numerical data | Antifungal Agents - administration & dosage | Antifungal Agents - blood | Index Medicus | Pharmacology
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2016, Volume 387, Issue 10020, pp. 760 - 769
Journal Article
JAMA ophthalmology, ISSN 2168-6165, 05/2014, Volume 132, Issue 7, pp. 832 - 837
IMPORTANCE Optisol-GS, the most common corneal storage medium in the United States, contains antibacterial but no antifungal supplementation. Most... 
VORICONAZOLE | PRESERVATION MEDIUM | DONOR CORNEAS | RIM CULTURES | PENETRATING KERATOPLASTY | ENDOTHELIAL-CELLS | SUSCEPTIBILITY | OPHTHALMOLOGY | FUNGAL ENDOPHTHALMITIS | EYE-BANKING | TRANSPLANTATION | Dextrans - adverse effects | Triazoles - adverse effects | Antifungal Agents - adverse effects | Cornea | Cell Count | Humans | Organ Preservation | Culture Media, Serum-Free - adverse effects | Drug Contamination - prevention & control | Colony Count, Microbial | Endothelium, Corneal - pathology | Candidiasis - microbiology | Microbial Sensitivity Tests | Candidiasis - prevention & control | Candida albicans - drug effects | Chondroitin Sulfates - adverse effects | Complex Mixtures - pharmacology | Endothelium, Corneal - microbiology | Dextrans - pharmacology | Gentamicins - pharmacology | Voriconazole | Culture Media, Serum-Free - pharmacology | Antifungal Agents - pharmacology | Organ Preservation Solutions - adverse effects | Gentamicins - adverse effects | Amphotericin B - pharmacology | Treatment Outcome | Chondroitin Sulfates - pharmacology | Organ Preservation Solutions - pharmacology | Endothelium, Corneal - drug effects | Pyrimidines - pharmacology | Complex Mixtures - adverse effects | Amphotericin B - adverse effects | Triazoles - pharmacology | Pyrimidines - adverse effects | Tissue Donors | Drug Combinations | Candida glabrata - drug effects | Care and treatment | Keratitis | Amphotericin B | Endophthalmitis | Dosage and administration | Diagnosis | Research | Risk factors | Fungal antigens
Journal Article
Book Review